Targeting BUB1 has been shown to be a promising strategy in osteosarcoma patients, where inhibition of the kinase markedly suppressed cell proliferation, migration, invasion, and induced apoptosis; in bladder cancer, BUB1 inhibition suppressed tumour progression30. Here, BUB1 is linked to urinary bladder cancer.